J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
1,605.45
-25.00 (-1.53%)
At close: Feb 21, 2025
BOM:506943 Revenue
J. B. Chemicals & Pharmaceuticals had revenue of 9.63B INR in the quarter ending December 31, 2024, with 14.09% growth. This brings the company's revenue in the last twelve months to 38.30B, up 13.16% year-over-year. In the fiscal year ending March 31, 2024, J. B. Chemicals & Pharmaceuticals had annual revenue of 34.84B with 10.63% growth.
Revenue (ttm)
38.30B
Revenue Growth
+13.16%
P/S Ratio
6.51
Revenue / Employee
7.21M
Employees
5,311
Market Cap
249.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 34.84B | 3.35B | 10.63% |
Mar 31, 2023 | 31.49B | 7.25B | 29.91% |
Mar 31, 2022 | 24.24B | 3.82B | 18.69% |
Mar 31, 2021 | 20.43B | 2.68B | 15.09% |
Mar 31, 2020 | 17.75B | 1.32B | 8.00% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
Tata Consultancy Services | 2,520.82B |
HDFC Bank | 2,702.59B |
Bharti Airtel | 1,627.08B |
ICICI Bank | 1,755.26B |
Infosys | 1,635.60B |
State Bank of India | 3,409.52B |
Hindustan Unilever | 626.61B |
J. B. Chemicals & Pharmaceuticals News
- 3 months ago - KKR Is Said to Consider Selling $750 Million Stake in JB Pharma - BNN Bloomberg
- 4 months ago - Stocks to Buy This Diwali: Kotak Securities sees JB Chemicals & Pharma reaching ₹2,255, with a 19.2% upside - Business Upturn
- 4 months ago - Pharma Stocks Update: Natco Pharma gains 2.99%, Glenmark rises 0.07%, Granules falls 3.83% - Business Upturn
- 5 months ago - Pharma Stocks Update: Granules up 3.56%, Ajanta Pharma gains 2.24% while JB Chemicals drops 2.82%, Mankind Pharma down 1.40% in mixed pharma stock performance - Business Upturn
- 5 months ago - JB Chemicals faces valuation dispute over KKR’s 54% equity stake, potential M&A deal withdrawal looms; stock falls 4.28% - Business Upturn
- 6 months ago - Torrent Is Said to Seek Raising $3 Billion for KKR’s Stake in JB - BNN Bloomberg